A Video Atlas of Neuromuscular Disorders

A Video Atlas of Neuromuscular Disorders is the essential reference on adult neuromuscular disorders and their diagnosis and treatment. Perfect for preparing for the neurology and neuromuscular boards, this book and accompanying videos have become an invaluable resource for neurology and neuromuscular training programs, while catering to the too-busy and often-overwhelmed modern doctor with its straightforward structure and language.

A Video Atlas of Neuromuscular Disorders is the essential reference on adult neuromuscular disorders and their diagnosis and treatment. Written with the busy Fellow, Resident, and clinician in mind, the work utilizes real clinic videos as the key teaching tools to demonstrate clinical symptoms and how neurologists identify and diagnose them. Perfect for preparing for the neurology and neuromuscular boards, this book and accompanying videos have become an invaluable resource for neurology and neuromuscular training programs, while catering to the too-busy and often-overwhelmed modern doctor with its straightforward structure and language. All videos are supplemented with challenging multiple-choice questions to test the reader''s knowledge and understanding. Each chapter is organized by cases, which start with a video, a description of the patient''s symptoms, multiple choice questions, the diagnosis, and key references. This third edition, comprised of a total of 311 video cases (46 new), has several exciting new features and text to reflect the rapid advancement of medicine. The COVID-19 pandemic (caused by SARS-CoV-2) imposed tremendous challenges to the field of neurology and new videos are included to illustrate COVID-19 related neuromuscular disorders such as neuropathies and plexopathies. Videos also explore the pros and cons of virtual medicine, a practice expedited by the pandemic. A new chapter on the use of ultrasound, with 19 cases of videos and discussion, is now included. Videos of muscle and nerve biopsies are also included, as well as information about several new medications for myasthenia gravis, ALS and amyloidosis.